AHK-Cu

AHK-Cu 50mg is a research-grade copper-binding tripeptide complex developed for laboratory investigations involving extracellular matrix biology, copper transport mechanisms, peptide-mediated cellular signaling, connective tissue biology, molecular biochemistry, and regenerative biology. The peptide consists of Alanine-Histidine-Lysine (AHK) coordinated with a copper ion (Cu²⁺), forming a stable investigational complex widely studied for its biochemical characteristics and molecular interactions. Its unique peptide sequence differentiates it from other copper peptides while providing researchers with an important model for investigating copper-dependent cellular communication and peptide biology.

One of the defining characteristics of AHK-Cu research is its relationship with copper homeostasis. Researchers investigate how AHK-Cu participates in copper binding, intracellular copper transport, trace element regulation, metalloprotein activity, and copper-dependent enzymatic systems. These investigations continue expanding scientific understanding of metal-ion biology and peptide-mediated biochemical regulation without implying approved therapeutic applications.

Scientific investigations also focus extensively on extracellular matrix (ECM) biology. Laboratory studies evaluate AHK-Cu interactions with molecular systems associated with collagen organization, elastin biology, extracellular matrix remodeling, glycosaminoglycan metabolism, structural protein regulation, and coordinated cellular communication. Researchers continue exploring these mechanisms to better understand connective tissue biology within controlled laboratory environments.

Another major area of investigation involves hair follicle biology and dermal cellular signaling. Researchers investigate peptide-mediated molecular communication involving follicular cell biology, dermal extracellular matrix organization, copper-dependent signaling pathways, and cellular protein regulation. These laboratory investigations remain focused on understanding molecular mechanisms and biological pathways rather than therapeutic outcomes.

Current laboratory investigations further evaluate intracellular signaling involving TGF-β, MAPK/ERK, PI3K/Akt, NF-κB, matrix metalloproteinases (MMPs), tissue inhibitors of metalloproteinases (TIMPs), copper-dependent enzymes, and additional molecular systems associated with extracellular matrix regulation and peptide signaling. Researchers investigate these pathways to better understand cellular communication, connective tissue biology, and metalloprotein regulation.

Comparative peptide research represents another major area of scientific interest. Researchers frequently compare AHK-Cu with GHK-Cu, BPC-157, TB-500, Glutathione, and additional investigational compounds to evaluate differences in copper-binding characteristics, molecular signaling, extracellular matrix interactions, biochemical stability, and laboratory applications. Comparative investigations continue expanding scientific understanding of peptide pharmacology and regenerative biology.

The 50mg presentation is particularly appropriate for institutional laboratory research, large-scale extracellular matrix investigations, hair follicle biology studies, extended peptide interaction research, analytical validation, biomarker discovery, comparative peptide investigations, and collaborative scientific initiatives requiring larger quantities of research-grade investigational material. Although the presentation size differs from lower-strength offerings, the molecular identity, manufacturing process, analytical quality standards, and intended laboratory applications remain consistent throughout the AHK-Cu product family.

Beyond extracellular matrix investigations, AHK-Cu serves as an important analytical reference material within peptide chemistry, analytical chemistry, molecular biology, metalloprotein research, biomaterials science, biomarker discovery, analytical method development, systems biology, and cellular physiology. Its reproducible analytical profile makes it valuable for laboratories investigating copper-peptide interactions and molecular signaling networks.

Each batch of AHK-Cu 50mg is manufactured according to research-grade production standards and undergoes comprehensive analytical verification before release. Quality assurance procedures include High-Performance Liquid Chromatography (HPLC) purity analysis, molecular identity confirmation, peptide sequence verification, copper complex validation, molecular weight characterization, and rigorous batch-specific quality control testing. These analytical measures support reproducibility, consistency, and confidence across independent laboratory investigations.

To preserve molecular integrity, AHK-Cu should be stored according to accepted laboratory recommendations for lyophilized peptides. Appropriate storage conditions, controlled handling practices, and adherence to established laboratory protocols help maintain peptide stability before analytical evaluation and experimental preparation.

Although AHK-Cu remains an actively investigated copper-binding peptide, ongoing scientific research continues exploring copper homeostasis, extracellular matrix biology, hair follicle biology, cellular signaling, metalloprotein regulation, and comparative peptide biology. Consequently, AHK-Cu 50mg should be regarded exclusively as an investigational research peptide intended to support laboratory research and scientific discovery.

AHK-Cu 50mg is supplied exclusively for laboratory research and analytical applications. This product is intended for Research Use Only (RUO) and is not approved for human consumption, therapeutic use, veterinary applications, or diagnostic purposes.